CH670090A5 - - Google Patents

Download PDF

Info

Publication number
CH670090A5
CH670090A5 CH4253/86A CH425386A CH670090A5 CH 670090 A5 CH670090 A5 CH 670090A5 CH 4253/86 A CH4253/86 A CH 4253/86A CH 425386 A CH425386 A CH 425386A CH 670090 A5 CH670090 A5 CH 670090A5
Authority
CH
Switzerland
Prior art keywords
compound
methylxanthine
hydroxybutyl
formula
hydroxypropyl
Prior art date
Application number
CH4253/86A
Other languages
English (en)
French (fr)
Inventor
Rene Fumeaux
Georges Philippossian
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Priority to CH4253/86A priority Critical patent/CH670090A5/fr
Priority to ZA877851A priority patent/ZA877851B/xx
Priority to DK551487A priority patent/DK169336B1/da
Priority to AU79980/87A priority patent/AU604767B2/en
Priority to EP87115591A priority patent/EP0269841B1/fr
Priority to AT87115591T priority patent/ATE82289T1/de
Priority to DE8787115591T priority patent/DE3782619T2/de
Priority to ES87115591T priority patent/ES2043631T3/es
Priority to IL84266A priority patent/IL84266A/xx
Priority to KR1019870011905A priority patent/KR930010559B1/ko
Priority to CA000550244A priority patent/CA1296001C/en
Priority to JP62271591A priority patent/JP2527769B2/ja
Publication of CH670090A5 publication Critical patent/CH670090A5/fr
Priority to GR920402559T priority patent/GR3006223T3/el
Priority to US07/998,876 priority patent/US5338741A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CH4253/86A 1986-10-27 1986-10-27 CH670090A5 (US07786301-20100831-C00010.png)

Priority Applications (14)

Application Number Priority Date Filing Date Title
CH4253/86A CH670090A5 (US07786301-20100831-C00010.png) 1986-10-27 1986-10-27
ZA877851A ZA877851B (en) 1986-10-27 1987-10-19 1-hydroxyalkylxanthines,processes for their preparation and medicaments containing them
DK551487A DK169336B1 (da) 1986-10-27 1987-10-21 1-Hydroxyalkylxanthiner, fremgangsmåde til fremstilling heraf samt farmaceutiske præparater med indhold af sådanne forbindelser
AU79980/87A AU604767B2 (en) 1986-10-27 1987-10-21 1-hydroxyalkylxanthines, processes for their preparation and medicaments containing them
ES87115591T ES2043631T3 (es) 1986-10-27 1987-10-23 Procedimiento de preparacion de hidroxialquilxantinas.
AT87115591T ATE82289T1 (de) 1986-10-27 1987-10-23 1-hydroxyalkylxanthine, verfahren zu ihrer herstellung und sie enthaltende medikamente.
DE8787115591T DE3782619T2 (de) 1986-10-27 1987-10-23 1-hydroxyalkylxanthine, verfahren zu ihrer herstellung und sie enthaltende medikamente.
EP87115591A EP0269841B1 (fr) 1986-10-27 1987-10-23 1-Hydroxyalkylxanthines, leurs procédés de préparation et médicament les contenant
IL84266A IL84266A (en) 1986-10-27 1987-10-25 1-hydroxyalkyl-3-alkylxanthines and pharmaceutical compositions containing them
KR1019870011905A KR930010559B1 (ko) 1986-10-27 1987-10-26 1-히드록시알킬크산틴류, 그의 제조방법
CA000550244A CA1296001C (en) 1986-10-27 1987-10-26 1-hydroxyalkylxanthines, processes for their preparation and medicaments containing them
JP62271591A JP2527769B2 (ja) 1986-10-27 1987-10-27 キサンチン誘導体およびその製造方法
GR920402559T GR3006223T3 (US07786301-20100831-C00010.png) 1986-10-27 1992-11-12
US07/998,876 US5338741A (en) 1986-10-27 1992-12-29 1-hydroxyalkylxanthines and medicaments containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4253/86A CH670090A5 (US07786301-20100831-C00010.png) 1986-10-27 1986-10-27

Publications (1)

Publication Number Publication Date
CH670090A5 true CH670090A5 (US07786301-20100831-C00010.png) 1989-05-12

Family

ID=4272668

Family Applications (1)

Application Number Title Priority Date Filing Date
CH4253/86A CH670090A5 (US07786301-20100831-C00010.png) 1986-10-27 1986-10-27

Country Status (13)

Country Link
EP (1) EP0269841B1 (US07786301-20100831-C00010.png)
JP (1) JP2527769B2 (US07786301-20100831-C00010.png)
KR (1) KR930010559B1 (US07786301-20100831-C00010.png)
AT (1) ATE82289T1 (US07786301-20100831-C00010.png)
AU (1) AU604767B2 (US07786301-20100831-C00010.png)
CA (1) CA1296001C (US07786301-20100831-C00010.png)
CH (1) CH670090A5 (US07786301-20100831-C00010.png)
DE (1) DE3782619T2 (US07786301-20100831-C00010.png)
DK (1) DK169336B1 (US07786301-20100831-C00010.png)
ES (1) ES2043631T3 (US07786301-20100831-C00010.png)
GR (1) GR3006223T3 (US07786301-20100831-C00010.png)
IL (1) IL84266A (US07786301-20100831-C00010.png)
ZA (1) ZA877851B (US07786301-20100831-C00010.png)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
DE4316576A1 (de) * 1993-05-18 1994-11-24 Boehringer Ingelheim Kg Verbessertes Verfahren zur Herstellung von 1,3-Dipropyl-8-(3-Oxocyclopentyl)-xanthin

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2517410A (en) * 1947-08-15 1950-08-01 Searle & Co Hydroxy alkyl xanthines and the production thereof
FR1211333A (fr) * 1955-10-19 1960-03-15 Boehringer Sohn Ingelheim Perfectionnements apportés aux procédés pour fabriquer des oxyalcoylxanthines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2517410A (en) * 1947-08-15 1950-08-01 Searle & Co Hydroxy alkyl xanthines and the production thereof
FR1211333A (fr) * 1955-10-19 1960-03-15 Boehringer Sohn Ingelheim Perfectionnements apportés aux procédés pour fabriquer des oxyalcoylxanthines

Also Published As

Publication number Publication date
EP0269841A1 (fr) 1988-06-08
DE3782619T2 (de) 1993-04-22
KR930010559B1 (ko) 1993-10-28
DK169336B1 (da) 1994-10-10
IL84266A (en) 1992-02-16
GR3006223T3 (US07786301-20100831-C00010.png) 1993-06-21
ES2043631T3 (es) 1994-01-01
AU604767B2 (en) 1991-01-03
CA1296001C (en) 1992-02-18
DK551487D0 (da) 1987-10-21
DE3782619D1 (de) 1992-12-17
JP2527769B2 (ja) 1996-08-28
ZA877851B (en) 1988-04-22
DK551487A (da) 1988-04-28
ATE82289T1 (de) 1992-11-15
AU7998087A (en) 1988-04-28
JPS63122683A (ja) 1988-05-26
KR880005131A (ko) 1988-06-28
IL84266A0 (en) 1988-03-31
EP0269841B1 (fr) 1992-11-11

Similar Documents

Publication Publication Date Title
CA1290756C (en) Quinazolinone derivative and processes for preparing the same
TWI496781B (zh) 製備｛４，６－二胺基－２－［１－（２－氟苯甲基）－１Ｈ－吡唑并［３，４－ｂ］吡啶－３－基］嘧啶－５－基｝甲基胺基甲酸甲酯之方法及其使用作為醫藥活性化合物之純化
EP0283390B1 (fr) Dérivés du thiazole actifs sur le système cholinergique, procédé d'obtention et compositions pharmaceutiques en contenant
EP0356333A1 (fr) Dérivés du thiadiazole-1,3,4, leur procédé d'obtention et compositions pharmaceutiques en contenant
EP0039780B1 (fr) Xanthines di- ou trisubstituées ayant des propriétés neuroleptiques, procédés de préparation et médicament les contenant
HU193409B (en) Process for producing 2-square bracket -n-cyclohexyl-4-bracket-oxo-1,2,3,5-tetrahydro-imidazo-square bracket-2,1-b-square bracket closed-quinazolin-7-yl-bracket closed-oxy-alkqne-carboxamidyl-square bracket closed-alkan-acides
CA2268166C (en) Pyrrolo[3,2-c]quinoline derivatives containing haloalkoxy group and pharmaceutically acceptable salts thereof
CH661507A5 (fr) Derives de l'hydroxymethyl-5 oxazolidinone-2 n-arylee et leur procede de preparation.
CH670090A5 (US07786301-20100831-C00010.png)
EP0000452B1 (fr) Dérivés d'oxadiazole-1,2,4, leur préparation et leur application en thérapeutique.
CH650254A5 (fr) Quinolones, leurs procedes de preparation et compositions therapeutiques les contenant.
BE779775A (fr) Derives de l'uree, procede pour les preparer et leurs applications
US6576764B2 (en) Synthesis and crystallization of piperazine ring-containing compounds
EP0234970B1 (fr) Dérivés d'acylaminométhyl-3 imidazo[1,2-a]pyridines, leur préparation et leur application en thérapeutique
BE897208A (fr) Composes de carbostyryle
US3029239A (en) Basic substituted 1-and 7-alkylxanthines or salts thereof
EP0450039B1 (fr) Derives de dihydro-1,2 oxo-2 quinoxalines, leur preparation et leur application en therapeutique
WO1999031097A1 (fr) Derives d'imidazole en tant qu'antagonistes des recepteurs muscariniques m3
HU202506B (en) Process for producing benzoxazolone derivatives
EP0613470B1 (fr) Nouveaux derives de cinnolinones-4, leur preparation et leur application en therapeutique
WO2000063170A1 (fr) Derives de cyclobutene-3,4-dione en tant qu'inhibiteurs de la phosphodiesterase 5
EP0663903B1 (fr) Derives de dihydro-1,2 oxo-2 amino-3 quinoxalines, leur preparation et leur application en therapeutique
EP0609457B1 (en) Benzene derivative
US5338741A (en) 1-hydroxyalkylxanthines and medicaments containing them
EP0015817A1 (fr) Nouveaux dérivés de la pipéridine, leur procédé de préparation et leur application en thérapeutique

Legal Events

Date Code Title Description
PL Patent ceased